GlassScriptPhysician profile
Timothy Hanna
NPI 1841588696
$1,612.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $124 · 2021: $274 · 2022: $229.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $411.17 | 2019-2021 | |
| Stryker Corporation | $360.12 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $140.74 | 2019-2022 | |
| Boston Scientific Corporation | $131.15 | 2022 | |
| Celularity INC. | $123.00 | 2019 | |
| Philips North America LLC | $120.53 | 2019 | |
| Organogenesis INC. | $86.77 | 2019-2022 | |
| Misonix INC | $46.02 | 2019 | |
| Paragon 28, INC. | $35.00 | 2019-2020 | |
| Sanara Medtech INC. | $32.85 | 2021 | |
| Merck Sharp & Dohme LLC | $28.38 | 2019 | |
| Medline Industries LP | $26.10 | 2019 | |
| Abbvie INC. | $23.17 | 2021 | |
| Djo, LLC | $20.44 | 2019 | |
| Horizon Therapeutics Plc | $14.68 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $12.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.